KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Current Deferred Revenue (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Current Deferred Revenue for 9 consecutive years, with $416.0 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 25.3% to $416.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $416.0 million through Dec 2025, up 25.3% year-over-year, with the annual reading at $416.0 million for FY2025, 25.3% up from the prior year.
  • Current Deferred Revenue hit $416.0 million in Q4 2025 for Elanco Animal Health, up from $376.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $416.0 million in Q4 2025 to a low of $284.0 million in Q2 2022.
  • Historically, Current Deferred Revenue has averaged $334.0 million across 5 years, with a median of $330.0 million in 2021.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 84.76% in 2021 and later dropped 10.27% in 2022.
  • Year by year, Current Deferred Revenue stood at $319.0 million in 2021, then rose by 1.57% to $324.0 million in 2022, then increased by 13.27% to $367.0 million in 2023, then fell by 9.54% to $332.0 million in 2024, then increased by 25.3% to $416.0 million in 2025.
  • Business Quant data shows Current Deferred Revenue for ELAN at $416.0 million in Q4 2025, $376.0 million in Q3 2025, and $367.0 million in Q2 2025.